SS Innovations Conducts First Robotic Heart Surgery in Indonesia
SS Innovations, the developer of India’s first indigenous surgical robotic system has successfully performed the first-ever robotic cardiac surgery in Indonesia. This achievement not only marks a significant milestone for the island nation but also highlights the transformative potential of SSI Mantra, SS Innovations’ state-of-the-art surgical robotic system, and reinforces the company’s commitment to making advanced robotic surgeries cost-effective and globally accessible.
The procedures, a bilateral IMA CABG (Coronary Artery Bypass Graft), and ASD Repair and Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB), were conducted at the Harapan Kita National Cardiac Hospital in Jakarta. This marks a significant milestone for both the hospital and Indonesia’s healthcare sector, showcasing the advancements made possible through the use of SSI Mantra.
Further, at the core of this accomplishment is Dr. Sudhir Srivastava, the visionary founder, chairman, and CEO of SS Innovations. Renowned globally for his expertise in robotic cardiac surgery, Dr. Srivastava personally performed the first Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) in Indonesia, accompanied by his team from SS Innovations and the dedicated support staff of Harapan Kita led by Dr. Dudy Hanafy. This achievement showcases the capabilities of SSI Mantra Surgical Robotic System and reflects Dr. Srivastava’s leadership, blending his entrepreneurial vision with surgical expertise. Very few robotic companies in the world can claim that their Chairman and CEO is also a surgeon capable of performing such complex procedures.
The launch of the robotic cardiac surgery program at Harapan Kita represents the beginning of a new era in cardiac care in Indonesia. Over the next few days, SS Innovations, in collaboration with Harapan Kita’s surgical team, will perform 7-8 additional robotic-assisted procedures, including LIMA, BIMA, Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB), and ASD Repair. This collaboration aims to elevate the standard of cardiac care in the region.
Celebrating the remarkable achievement, SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava, said, “This collaboration addresses the critical need for safe, timely, and affordable cardiac care while offering patients less invasive options and an improved quality of life. The successful use of SSI Mantra in cardiac surgeries positions us to accelerate momentum, gain market share in key procedural territories, and continue our mission of making robotic surgery accessible to patients worldwide.”
Dr. Iwan Dakota, Director and Intervention Cardiologist at NCVC Harapan Kita, said, “We’ve been exploring the integration of robotic surgery in cardiovascular care at the Harapan Kota hospital and reviewed the available surgical robotic systems globally. We found that Mantra is the only system supporting the full spectrum of robotic cardiac surgery, including Totally Endoscopic Coronary Artery Bypass (TECAB). Given its unique capabilities, we invited Dr. Sudhir Srivastava’s team to demonstrate how Mantra outperforms other systems. The potential for implementing robotic surgery in our country is highly promising.”
The successful completion of the first cardiac surgery in Indonesia positions SSI Mantra as a key player in the future of surgical robotics.
